Dihydroergocryptine

From WikiMD.com - Food, Medicine & Wellness Encyclopedia

An ergot alkaloid used in the treatment of Parkinson's disease


Dihydroergocryptine
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG


Dihydroergocryptine is a dopamine receptor agonist belonging to the class of ergot alkaloids. It is primarily used in the management of Parkinson's disease and has been studied for its potential benefits in treating other neurological disorders.

Pharmacology[edit | edit source]

Dihydroergocryptine acts as an agonist at dopamine receptors, particularly the D2 subtype, which plays a crucial role in the modulation of motor control and coordination. By stimulating these receptors, dihydroergocryptine helps to alleviate the symptoms of Parkinson's disease, such as tremor, rigidity, and bradykinesia.

Mechanism of Action[edit | edit source]

The mechanism of action of dihydroergocryptine involves its interaction with the dopaminergic system. It binds to dopamine receptors in the central nervous system, mimicking the effects of dopamine, a neurotransmitter that is deficient in patients with Parkinson's disease. This action helps to restore the balance of neurotransmitters in the brain, improving motor function and reducing symptoms.

Clinical Use[edit | edit source]

Dihydroergocryptine is used as a monotherapy or as an adjunct to levodopa in the treatment of Parkinson's disease. It is particularly beneficial in the early stages of the disease and can help to delay the need for levodopa therapy. The drug is administered orally and is well-tolerated by most patients.

Side Effects[edit | edit source]

Common side effects of dihydroergocryptine include nausea, vomiting, dizziness, and orthostatic hypotension. In some cases, patients may experience hallucinations or confusion, particularly at higher doses. Long-term use of ergot derivatives has been associated with fibrotic complications, although this is less common with dihydroergocryptine compared to other ergot alkaloids.

Chemical Structure[edit | edit source]

Structural formula of dihydroergocryptine

Dihydroergocryptine is a semi-synthetic derivative of ergotamine, an alkaloid derived from the Claviceps purpurea fungus. Its chemical structure is characterized by a complex tetracyclic ergoline ring system, which is responsible for its pharmacological activity.

Related pages[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Transform your life with W8MD's budget GLP1 injections from $125

W8mdlogo.png
W8MD weight loss doctors team

W8MD offers a medical weight loss program NYC and a clinic to lose weight in Philadelphia. Our W8MD's physician supervised medical weight loss centers in NYC provides expert medical guidance, and offers telemedicine options for convenience.

Why choose W8MD?

Book Your Appointment

Start your NYC weight loss journey today at our NYC medical weight loss, and Philadelphia medical weight loss Call (718)946-5500 for NY and 215 676 2334 for PA

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's NYC physician weight loss.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available. Call 718 946 5500.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD